« Back
Home /
UCP2 Antibody

UCP2 Antibody

Manufacturer	Cusabio
Category	Neuroscience Neural Mitochondrial Function Antibodies Immunohistochemistry Western Blot ELISA Primary Antibodies
Type	Antibody Polyclonal
Specific against	Human, Mouse, Rat
Isotype	IgG
Format	Liquid
Applications	WB, IHC, ELISA
Amount	50ul
Host	Rabbit
Item no.	CSB-PA299698-50ul
Targets	UCP2
eClass 6.1	32160702
eClass 9.0	32160702
Available
Immunogen Species	Human
UniprotID	P55851
Immunogen	Synthetic peptide of human UCP2
Applications info	ELISA, WB, IHC, ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:10-1:50
Dilution ratio 1	ELISA:1:1000-1:2000
Dilution ratio 2	WB:1:200-1:1000
Dilution ratio 3	IHC:1:10-1:50
Background	Mitochondrial uncoupling proteins (UCP) are members of the larger family of mitochondrial anion carrier proteins (MACP). UCPs separate oxidative phosphorylation from ATP synthesis with energy dissipated as heat, also referred to as the mitochondrial proton leak. UCPs facilitate the transfer of anions from the inner to the outer mitochondrial membrane and the return transfer of protons from the outer to the inner mitochondrial membrane. They also reduce the mitochondrial membrane potential in mammalian cells.
Conjugate	Non-conjugated
Buffer	-20C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
Storage	Upon receipt, store at -20C or -80C. Avoid repeated freeze.
Purification Method	Antigen affinity purification
General Research Areas	Cancer, Metabolism
Initial Research Areas	Cancer

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

CSB-PA299698-50ul-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 50ul

available

Delivery expected until 6/13/2024